Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
125,955,831
-
Total 13F shares
-
11,501
-
Share change
-
+11,501
-
Total reported value
-
$25,420
-
Price per share
-
$2.24
-
Number of holders
-
7
-
Value change
-
+$25,420
-
Number of buys
-
7
Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q2 2024
As of 30 Jun 2024,
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,501 shares.
The largest 7 holders included
UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, NVWM, LLC, MORGAN STANLEY, Addison Advisors LLC, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.